Goldman Sachs Gets Firm On Solid Biosciences By: Benzinga via Benzinga February 20, 2018 at 13:25 PM EST Just weeks into its life as a publicly traded company, Solid Biosciences Inc (NASDAQ: SLDB) caught the eyes of four analysts who assumed ... Read More >> Related Stocks: Pfizer Sarepta Therapeutics Solid Biosciences Inc
